Kortikosteroidna krema-nuspojave

processing.... Drugs & Diseases > Protocols Topical Corticosteroids  Updated: Aug 19, 2015

  • Author: Abimbola Farinde, PharmD, PhD; more...
  • Share
  • Email
  • Print
  • Feedback
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
Sections Topical Corticosteroids
  • Sections Topical Corticosteroids
  • World Health Organization Classification of Topical Corticosteroids
  • References
World Health Organization Classification of Topical Corticosteroids The potency of a topical corticosteroid depends on the formulation. Potency is also increased when a formulation is used under occlusive dressing or in intertriginous areas. In general, ointments are more potent than creams or lotions. [ 1 ]

Osteoporosis is particularly common in smokers, postmenopausal women, the elderly, underweight or immobile, and patients with diabetes or lung problems. Osteoporosis may result in fractures of the spine, ribs or hip joint with minimal trauma. These occur after the first year in 10–20% of patients treated with more than mg prednisone daily. It is estimated that up to 50% of patients on long-term prednisone will develop bone fractures. Vertebral fractures are more common in patients on steroids, even in those with normal bone density.

Kortikosteroidna krema-nuspojave

kortikosteroidna krema-nuspojave


kortikosteroidna krema-nuspojavekortikosteroidna krema-nuspojavekortikosteroidna krema-nuspojavekortikosteroidna krema-nuspojavekortikosteroidna krema-nuspojave